Search Results

Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p

Authors: Broisat, A.; Riou, L.; Ardisson, V.; Boturyn, D.; Dumy, P.; Fagret, D.; Ghezzi, C.

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 34, Number 6, June 2007 , pp. 830-840(11)

Publisher: Springer

N,N-Diacetyl-l-cystine Improves Endothelial Function in Atherosclerotic Watanabe Heritable Hyperlipidaemic Rabbits

Authors: Pettersson, Knut S.; Eliasson, Ulla Brandt; Abrahamsson, Tommy; Wågberg, Maria; Carrier, Martin; Kengatharan, Ken M.

Source: Basic & Clinical Pharmacology & Toxicology, Volume 100, Number 1, January 2007 , pp. 36-42(7)

Publisher: Blackwell Publishing

Ocular lesions in Watanabe heritable hyperlipidemic rabbits

Authors: Kouchi, Mami; Ueda, Yoshinaka; Horie, Hiroshi; Tanaka, Kohji

Source: Veterinary Ophthalmology, Volume 9, Number 3, May 2006 , pp. 145-148(4)

Publisher: Blackwell Publishing

Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin

Authors: Yamaguchi Y.; Matsuno S.; Kagota S.; Haginaka J.; Kunitomo M.

Source: Atherosclerosis, Volume 172, Number 2, February 2004 , pp. 259-265(7)

Publisher: Elsevier

Long-term estradiol treatment improves VIP-mediated vasodilation in atherosclerotic proximal coronary arteries

Authors: Dalsgaard T.; Mortensen A.; Larsen C.R.; Larsen J.J.; Ottesen B.

Source: Regulatory Peptides, Volume 116, Number 1, 15 November 2003 , pp. 155-162(8)

Publisher: Elsevier

Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia

Authors: Amano Y.; Nishimoto T.; Tozawa R.-i.; Ishikawa E.; Imura Y.; Sugiyama Y.

Source: European Journal of Pharmacology, Volume 466, Number 1, 11 April 2003 , pp. 155-161(7)

Publisher: Elsevier

Patterns of oxidized epitopes, but not NF-B expression, change during atherogenesis in WHHL rabbits

Authors: Brasen J.H.; Hakkinen T.; Malle E.; Beisiegel U.; Yla-Herttuala S.

Source: Atherosclerosis, Volume 166, Number 1, January 2003 , pp. 13-21(9)

Publisher: Elsevier

Novel findings of coronary compensatory enlargement of WHHL rabbits by a newly developed analysis - M. Shiomi¹, T. Ito¹, K. Yoshida², M. Hasegawa³. ¹Kobe University School of Medicine; ²Chiba University Graduate School of Medicine; ³National Cardiovascular Center Research Institute, Kobe, Japan

Source: Atherosclerosis, Supplements, Volume 3, Number 2, October 2002 , pp. 205-205(1)

Publisher: Elsevier

Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits

Authors: Murakami S.; Kondo Y.; Sakurai T.; Kitajima H.; Nagate T.

Source: Atherosclerosis, Volume 163, Number 1, July 2002 , pp. 79-87(9)

Publisher: Elsevier

New animal model for the study of postmenopausal coronary and cerebral artery function: the Watanabe heritable hyperlipidemic rabbit fed on a diet avoiding phytoestrogens

Authors: Dalsgaard T.; Larsen C.R.; Mortensen A.; Larsen J.J.; Ottesen B.

Source: Climacteric, Volume 5, Number 2, 1 June 2002 , pp. 178-189(12)

Publisher: Informa Healthcare

pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque

Authors: Naghavi M.; John R.; Naguib S.; Siadaty M.S.; Grasu R.; Kurian K.C.; van Winkle W.B.; Soller B.; Litovsky S.; Madjid M.; Willerson J.T.; Casscells W.

Source: Atherosclerosis, Volume 164, Number 1, September 2002 , pp. 27-35(9)

Publisher: Elsevier

Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits

Authors: Yoshida N.; Murase H.; Kunieda T.; Toyokuni S.; Tanaka T.; Terao J.; Naito Y.; Tanigawa T.; Yoshikawa T.

Source: Atherosclerosis, Volume 162, Number 1, May 2002 , pp. 111-117(7)

Publisher: Elsevier

Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress

Authors: Yamaguchi Y.; Matsuno S.; Kagota S.; Haginaka J.; Kunitomo M.

Source: European Journal of Pharmacology, Volume 436, Number 1, 1 February 2002 , pp. 97-105(9)

Publisher: Elsevier

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

Authors: Hiyoshi H.; Yanagimachi M.; Ito M.; Saeki T.; Yoshida I.; Okada T.; Ikuta H.; Shinmyo D.; Tanaka K.; Kurusu N.; Tanaka H.

Source: European Journal of Pharmacology, Volume 431, Number 3, 23 November 2001 , pp. 345-352(8)

Publisher: Elsevier

MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion

Authors: Shiomi M.; Ito T.

Source: European Journal of Pharmacology, Volume 431, Number 1, 9 November 2001 , pp. 127-131(5)

Publisher: Elsevier

Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins

Authors: Shiomi M.; Ito T.; Hirouchi Y.; Enomoto M.

Source: Atherosclerosis, Volume 157, Number 1, July 2001 , pp. 75-84(10)

Publisher: Elsevier

Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits

Authors: Ito T.; Shiomi M.

Source: Atherosclerosis, Volume 156, Number 1, May 2001 , pp. 57-66(10)

Publisher: Elsevier

Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits

Authors: Yamaguchi Y.; Matsuno S.; Kagota S.; Haginaka J.; Kunitomo M.

Source: Atherosclerosis, Volume 156, Number 1, May 2001 , pp. 109-117(9)

Publisher: Elsevier

Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas

Authors: Clubb F.J.; Cerny J.L.; Deferrari D.A.; Butler-Aucoin M.M.; Willerson J.T.; Buja L.M.

Source: Cardiovascular Pathology, Volume 10, Number 1, 2 January 2001 , pp. 1-11(11)

Publisher: Elsevier

Fluvastatin Normalizes The Decreased Turnovers Of Glutathione And Ascorbic Acid In Watanabe Heritable Hyperlipidaemic Rabbits

Authors: Suzumura, Kuniharu; Kasahara, Emiko; Ohnishi, Yasuyo; Chien, Kuang-Chang; Inoue, Masayasu

Source: Clinical and Experimental Pharmacology and Physiology, Volume 27, Number 9, September 2000 , pp. 709-714(6)

Publisher: Blackwell Publishing